Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | TNKS | O95271 | 2/20 | 0.32 |
| ▸ | TNKS2 | Q9H2K2 | 2/20 | 0.32 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | MMP14 | P50281 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22273916 | 0.99 | MEN1 (0.36) | MEN1KMT2AATMTNKSTNKS2 | |
| SCHEMBL22274035 | 0.95 | MEN1 (0.36) | MEN1KMT2AATMTNKSTNKS2 | |
| SCHEMBL22274025 | 0.94 | TNKS (0.31) | MEN1KMT2ATNKSTNKS2LIMK1 | |
| SCHEMBL22273917 | 0.93 | ERBB2 (0.32) | MEN1KMT2AATMALOX5 | |
| SCHEMBL22273901 | 0.89 | MEN1 (0.34) | MEN1KMT2AATMTNKSTNKS2 | |
| SCHEMBL22273896 | 0.89 | MEN1 (0.34) | MEN1KMT2AATMTNKSTNKS2 | |
| SCHEMBL22274032 | 0.89 | ALOX5 (0.33) | MEN1KMT2AATMLIMK1ALOX5 | |
| SCHEMBL24280858 | 0.85 | ALOX5 (0.42) | MEN1KMT2AATMTNKSTNKS2 | |
| SCHEMBL22274343 | 0.84 | MEN1 (0.36) | MEN1KMT2AATM | |
| SCHEMBL22273897 | 0.84 | ERBB2 (0.31) | MAPTALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220085298-A1 | COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE | LT MATERIALS CO., LTD. (KR) | 2022-03-17 | — | — | US | disclosed |
| WO-2020153758-A1 | COMPOSITION, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE | 엘티소재주식회사 | 2020-07-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220085298-A1 | COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE | ALDH1A2, OXER1, AOX1 | MEN1 3195/4885KMT2A 3054/4885ATM 3762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.